Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2023 00:45 ET | Source: Nykode Therapeutics ASA

Nykode Therapeutics to Present at the mRNA Cancer Vaccines Summit 2023 in Boston

Nykode’s APC targeted vaccine technology can be delivered as mRNA and generate strong T cell responsesNykode’s APC targeted vaccine technology consistently results in faster, broader and stronger...
September 20, 2023 10:06 ET | Source: Nykode Therapeutics ASA

Nykode Therapeutics Announces Advances in Clinical Pipeline and Research

On-track to leverage promising Phase 2 cervical cancer data with FDA clearance to start a potentially registrational trial in 2023, and expansion into head and neck, two areas with high unmet...
September 05, 2023 01:00 ET | Source: Nykode Therapeutics ASA

Nykode Therapeutics Announces FDA Approval of IND for VB-C-04, a Trial of VB10.16 in HPV16-Positive Cervical Cancer

FDA approval of IND for VB-C-04 trial.Nykode to further elaborate on trial design and development strategy at upcoming capital markets day in New York on September 20. OSLO, Norway, Sept. 05,...
August 23, 2023 00:45 ET | Source: Nykode Therapeutics ASA

Nykode Therapeutics - Quarterly report Q2 2023

OSLO, Norway, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies,...